Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Aurobindo Pharma Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

16 May 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - AUROBINDO PHARMA LTD (AUROPHARMA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

26 May 2015 Thomson Reuters Stock Report 11 $25.00

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review Summary Aurobindo Pharma Ltd (Aurobindo Pharma) is a phar...

04 May 2015 GlobalData 35 $125.00

Wright Investors Service Comprehensive Report for Aurobindo Pharma Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

26 Apr 2015 Wright Reports 55 $75.00

Company Snapshot - Aurobindo Pharma Limited

A director at Aurobindo Pharma Limited sold 75,000 shares at 1,338.100INR and the significance rating of the trade was 86/100...

14 Apr 2015 Directors Deals Ltd. 1 $12.00

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review Summary Aurobindo Pharma Ltd (Aurobindo Pharma) is a phar...

17 Mar 2015 GlobalData 33 $125.00

Aurobindo Pharma (ARBP) - Qtr. Update - Dated - February 05, 2015

Aurobindo Pharma’s (Bloomberg: ARBP IN) Q3 revenue (up 48% YoY at Rs 32 bn) was 4% above estimates led by ARV revenue (up 51%...

06 Feb 2015 Axis Capital Limited 5 $46.00

Aurobindo Pharma | Q3FY15 Result/Concall Update | Outlook remains optimistic | We maintain BUY rating on the stock with revised PT of Rs1,412 (from Rs1,293 earlier)

Aurobindo Pharma | Q3FY15 Result/Concall Update Outlook remains optimistic | We maintain BUY rating on the stock with revi...

06 Feb 2015 IndiaNivesh Securities Pvt Ltd 5 $46.00

Aurobindo Pharma | Q3FY15 First Cut Analysis | Strong y-y growth in earnings takes a break. We have BUY rating on the stock with price target of Rs1,293

Aurobindo Pharma | Q3FY15 First Cut Analysis Strong y-y growth in earnings takes a break. We have BUY rating on the stock ...

04 Feb 2015 IndiaNivesh Securities Pvt Ltd 4 $35.00

Company Snapshot - Aurobindo Pharma Limited

A director at Aurobindo Pharma Limited sold 50,000 shares at 1,020.048INR and the significance rating of the trade was 80/100...

11 Nov 2014 Directors Deals Ltd. 1 $12.00